Alkaloids of Australia Slapped With Criminal Cartel Charges
33 Cases Registered Against The Scopolamine N-butylbromide API Supplier
Alkaloids of Australia has been charged with 33 criminal cartel offences for price fixing, market and customer allocation, and bid rigging by the Australian Competition and Consumer Commission. The allegations revolve around scopolamine N-butylbromide.
You may also be interested in...
To increase transparency and affordability, American billionaire and businessman Mark Cuban has launched a US generics venture under the name ‘the Mark Cuban Cost Plus Drugs Company.’ Cuban’s new company is hoping to introduce over 100 drugs by the end of 2021 and build a pharmaceutical factory of its own by 2022.
Teva has disclosed plans to focus on climate action and resilience, responsible use of natural resources and emissions, effluents and waste, as part of a long-term environmental sustainability commitment. Meanwhile, Hikma has at the same time committed “to further reducing our climate impact and improving the resilience of our business in the face of future climate change.”
Medicines for Europe has highlighted the need for an improved digital strategy across the EU in order to improve patient information and access to medicines, among other benefits like reducing the risk of supply disruptions, especially in the context of the current pandemic.